One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Superdisintegrants Market

[ 英語タイトル ] Superdisintegrants Market by Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin), Formulation (Tablet, Capsules), Therapeutic Area (Gastrointestinal, Cardiovascular, Neurology, Oncology, Hematology) - Global Forecast to 2023


Product Code : MNMHC00110183
Survey : MarketsandMarkets
Publish On : February, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The global superdisintegrants market is projected to grow at a CAGR of 7.9%.”
The superdisintegrants market is expected to reach USD 536.5 million by 2023 from an estimated USD 366.4 million in 2018, at a CAGR of 7.9%. The increasing adoption of orally disintegrating tablets, growing generics market, and emergence of new superdisintegrants for the pharmaceutical industry are the factors driving the market for superdisintegrants. The shifting focus of pharmaceutical manufacturing to emerging markets and the growth of the overall pharmaceutical sector in these markets present significant opportunities for the superdisintegrants market growth. However, safety and quality concerns are expected to challenge the growth of the superdisintegrants market to a certain extent during the forecast period.

“The synthetic superdisintegrants segment is expected to register the highest CAGR during the forecast period.”
By type, the superdisintegrants market is segmented into natural superdisintegrants, synthetic superdisintegrants, and other superdisintegrants. The synthetic superdisintegrants segment is further subsegmented into modified starch, cross-linked polyvinylpyrrolidone (crospovidone), modified cellulose, ion exchange resins, and calcium silicates. The synthetic superdisintegrants segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the widespread use of these superdisintegrants in various oral drug formulations, especially in orally disintegrating tablets.

“Tablet formulation segment is expected to witness the highest growth during the forecast period.”
By formulation, the superdisintegrants market is segmented into tablets and capsules. The tablets segment is expected to witness the highest CAGR owing to the widespread use of orally disintegrating tablets (ODT) and fast-disintegrating tablets among healthcare providers and patients driven by the advantages such as increasing drug bioavailability, better pregastric absorption, ease of swallowing in patients with dysphagia, ease of administration, and improved shelf life.

“APAC superdisintegrants market is projected to witness the highest growth during the forecast period.”
Europe held the largest share of the global superdisintegrants market in 2017. On the other hand, the APAC superdisintegrants market is expected to witness the highest CAGR during the forecast period, owing to the significant growth in pharmaceutical manufacturing in the past few years, low-cost manufacturing advantage, increasing per capita income, low regulatory stringency, and growing interest of key players in APAC countries.

Break of primary participants was as mentioned below:
• By Company Type: Tier 1–48%, Tier 2–34% and Tier 3–18%
• By Designation: C-level–42%, Director Level–40%, Others–18%
• By Region: North America–38%, Europe–32%, Asia Pacific–21%, Latin America–6%, Middle East & Africa–3%

The prominent players in the global superdisintegrants market are Ashland Inc. (US), BASF SE (Germany), DowDuPont (US), JRS Pharma (Germany), DFE Pharma (Germany), Roquette (France), Asahi Kasei Corporation (Japan), Merck KGaA (Germany), Corel Pharma Chem (India), and Avantor Performance Materials, LLC (US).

Research Coverage:
The report analyzes the various superdisintegrants products and their adoption pattern. It aims at estimating the market size and future growth potential of the global superdisintegrants market for different segments by type, formulation, therapeutic area, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the global superdisintegrants market
• Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and product launches in the global superdisintegrants market
• Market Development: Comprehensive information on the lucrative and emerging market
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global superdisintegrants market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global superdisintegrants market

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 18
1.3.1 MARKETS COVERED 19
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 20
1.5 STAKEHOLDERS 21
1.6 LIMITATIONS 21
2 RESEARCH METHODOLOGY 22
2.1 RESEARCH APPROACH 22
2.1.1 SECONDARY RESEARCH 23
2.1.1.1 Key data from secondary sources 23
2.1.2 PRIMARY RESEARCH 24
2.1.2.1 Key data from primary sources 24
2.1.2.2 Break down of primaries 25
2.1.2.3 Key industry insights 25
2.2 MARKET SIZE ESTIMATION 26
2.3 DATA TRIANGULATION APPROACH 28
2.4 MARKET SHARE ESTIMATION 29
2.5 ASSUMPTIONS FOR THE STUDY 29
3 EXECUTIVE SUMMARY 30
4 PREMIUM INSIGHTS 35
4.1 SUPERDISINTEGRANTS MARKET OVERVIEW 35
4.2 SUPERDISINTEGRANTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 36
4.3 REGIONAL MIX: SUPERDISINTEGRANTS MARKET (2018–2023) 37
4.4 SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE AND REGION (2017) 38
4.5 SUPERDISINTEGRANTS MARKET: DEVELOPED VS. DEVELOPING MARKETS, 2018 VS 2023 39
5 MARKET OVERVIEW 40
5.1 INTRODUCTION 40
5.2 MARKET DYNAMICS 40
5.2.1 MARKET DRIVERS 41
5.2.1.1 Growing adoption of orally disintegrating tablets 41
5.2.1.2 Growing generics market 42
5.2.1.3 Emergence of new superdisintegrants for the pharmaceutical industry 43
5.2.2 MARKET OPPORTUNITIES 44
5.2.2.1 Pharmaceutical market expansion in emerging countries 44
5.2.3 MARKET CHALLENGES 45
5.2.3.1 Safety and quality concerns 45
6 REGULATORY ANALYSIS 46
6.1 INTRODUCTION 46
6.2 NORTH AMERICA 46
6.2.1 US 46
6.2.2 CANADA 47
6.3 EUROPE 48
6.4 ASIA PACIFIC 49
6.4.1 JAPAN 49
6.4.2 CHINA 50
6.4.3 INDIA 50
7 SUPERDISINTEGRANTS MARKET, BY TYPE 52
7.1 INTRODUCTION 53
7.2 SYNTHETIC SUPERDISINTEGRANTS 54
7.2.1 CROSPOVIDONE 56
7.2.2 MODIFIED STARCH (SODIUM STARCH GLYCOLATE) 57
7.2.3 MODIFIED CELLULOSE 59
7.2.3.1 Croscarmellose sodium 60
7.2.3.2 Low-substituted hydroxypropyl cellulose 61
7.2.4 CALCIUM SILICATES 62
7.2.5 ION EXCHANGE RESINS 63
7.3 NATURAL SUPERDISINTEGRANTS 64
7.4 OTHER SUPERDISINTEGRANTS 65
8 SUPERDISINTEGRANTS MARKET, BY FORMULATION 66
8.1 INTRODUCTION 67
8.2 TABLETS 68
8.3 CAPSULES 69
9 SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA 71
9.1 INTRODUCTION 72
9.2 NEUROLOGICAL DISEASES 73
9.3 GASTROINTESTINAL DISEASES 75
9.4 ONCOLOGY 77
9.5 INFLAMMATORY DISEASES 79
9.6 INFECTIOUS DISEASES 81
9.7 CARDIOVASCULAR DISEASES 83
9.8 HEMATOLOGICAL DISEASES 85
10 SUPERDISINTEGRANTS MARKET, BY REGION 87
10.1 INTRODUCTION 88
10.2 EUROPE 89
10.2.1 SWITZERLAND 94
10.2.2 GERMANY 97
10.2.3 ITALY 99
10.2.4 FRANCE 102
10.2.5 UK 104
10.2.6 SPAIN 107
10.2.7 REST OF EUROPE 109
10.3 NORTH AMERICA 112
10.3.1 US 116
10.3.2 CANADA 119
10.4 ASIA PACIFIC 122
10.4.1 JAPAN 126
10.4.2 CHINA 129
10.4.3 INDIA 132
10.4.4 REST OF ASIA PACIFIC 135
10.5 LATIN AMERICA 138
10.6 MIDDLE EAST & AFRICA 141
11 COMPETITIVE LANDSCAPE 144
11.1 OVERVIEW 144
11.2 COMPETITIVE SITUATION AND TRENDS 145
11.3 MARKET SHARE ANALYSIS 146

12 COMPANY PROFILES 149
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
12.1 BASF SE 149
12.2 ASHLAND GLOBAL HOLDINGS INC. 152
12.3 DOWDUPONT INC. 156
12.4 ROQUETTE FRERES 160
12.5 DFE PHARMA 163
12.6 JRS PHARMA 165
12.7 ASAHI KASEI CORPORATION 167
12.8 MERCK KGAA 169
12.9 COREL PHARMA CHEM 171
12.10 AVANTOR PERFORMANCE MATERIALS, LLC 172
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
13 APPENDIX 173
13.1 INSIGHTS OF INDUSTRY EXPERTS 173
13.2 DISCUSSION GUIDE 174
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 179
13.4 AVAILABLE CUSTOMIZATIONS 181
13.5 RELATED REPORTS 181
13.6 AUTHOR DETAILS 182

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+